Relmada Therapeutics Inc (RLMD)
3.49
-0.01
(-0.29%)
USD |
NASDAQ |
Oct 31, 16:00
3.49
0.00 (0.00%)
After-Hours: 20:00
Relmada Therapeutics Cash from Operations (TTM): -48.18M for June 30, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
June 30, 2024 | -48.18M |
March 31, 2024 | -48.19M |
December 31, 2023 | -51.66M |
September 30, 2023 | -77.29M |
June 30, 2023 | -92.52M |
March 31, 2023 | -100.88M |
December 31, 2022 | -103.80M |
September 30, 2022 | -105.58M |
June 30, 2022 | -99.63M |
March 31, 2022 | -95.22M |
December 31, 2021 | -91.87M |
September 30, 2021 | -61.14M |
June 30, 2021 | -52.73M |
March 31, 2021 | -40.47M |
December 31, 2020 | -27.81M |
September 30, 2020 | -23.41M |
June 30, 2020 | -14.58M |
March 31, 2020 | -11.64M |
September 30, 2019 | -11.36M |
June 30, 2019 | -10.50M |
March 31, 2019 | -9.097M |
Date | Value |
---|---|
December 31, 2018 | -8.710M |
September 30, 2018 | -6.694M |
June 30, 2018 | -6.002M |
March 31, 2018 | -4.752M |
December 31, 2017 | -4.982M |
September 30, 2017 | -5.301M |
June 30, 2017 | -6.466M |
March 31, 2017 | -8.276M |
December 31, 2016 | -10.05M |
September 30, 2016 | -12.07M |
June 30, 2016 | -13.14M |
March 31, 2016 | -14.81M |
December 31, 2015 | -15.61M |
September 30, 2015 | -17.12M |
June 30, 2015 | -16.23M |
March 31, 2015 | -11.74M |
December 31, 2014 | -7.318M |
September 30, 2014 | -2.340M |
February 28, 2014 | -0.0231M |
November 30, 2013 | -0.0225M |
August 31, 2013 | -0.0119M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-105.58M
Minimum
Sep 2022
-11.64M
Maximum
Mar 2020
-63.70M
Average
-56.93M
Median
Cash from Operations (TTM) Benchmarks
Sensei Biotherapeutics Inc | -24.23M |
NovaBay Pharmaceuticals Inc | -3.388M |
Palatin Technologies Inc | -31.46M |
iBio Inc | -18.55M |
Theriva Biologics Inc | -17.83M |